DENTSPLY SIRONA Inc.
No SEC Form 4 filings for $XRAY in the last 30 days.
Dentsply Sirona (XRAY) shares fell about 7% after the company reported Q2 2026 results. Revenue declined 4.1% to $898 million and topped expectations, while adjusted EPS of $0.52 beat estimates. The stock dropped on a weaker full-year revenue forecast of $3.55 billion at the midpoint, about 1% below consensus.
Dentsply Sirona (NASDAQ:XRAY) reported Q2 CY2026 revenue of $898 million, down 4.1% year over year but 0.6% above market expectations. Full-year revenue guidance is $3.55 billion at the midpoint, about 1% below analysts’ estimates. Non-GAAP EPS was $0.52, 50.1% above consensus. Shares rose 1.8% to $13.42 after the release.
DENTSPLY SIRONA (XRAY) said Medline Sinclair will expand distribution of its full technology portfolio across Canada starting Sept. 1, 2026, broadening a prior consumables-focused partnership. The company expects this could help scale digital dentistry solutions. Investors also look to its Aug. 6 Q2 2026 results and guidance on transformation spending and demand pressures.
Over the past 7 days, alphai's AI scored 4 news stories mentioning XRAY (DENTSPLY SIRONA Inc.). Coverage has been balanced: 1 bullish, 2 neutral, and 1 bearish.
Recent XRAY coverage spans insider activity, earnings and financial news.
The earnings beat was outweighed by weaker forward revenue guidance, driving a risk-off repricing of XRAY’s growth outlook.
Beat on revenue and EPS, but full-year revenue guidance slightly below consensus, with margin contraction in Q2.
Broader Canadian channel access could modestly improve order flow and visibility for higher-value digital solutions, but the article frames it as incremental versus near-term earnings drivers.
Earnings are the primary catalyst, but the article provides no new guidance or datapoint beyond expectations and prior-quarter context.
The wrap highlights strong weekly gains and near-fair-value pricing.
alphai scores every news story that mentions XRAY with an AI model for sentiment and relevance, and aggregates insider trades from DENTSPLY SIRONA Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Dentsply Sirona (XRAY) shares fell about 7% after the company reported Q2 2026 results. Revenue declined 4.1% to $898 million and topped expectations, while adjusted EPS of $0.52 beat estimates. The stock dropped on a weaker full-year revenue forecast of $3.55 billion at the midpoint, about 1% below consensus.
3 min readDentsply Sirona (NASDAQ:XRAY) reported Q2 CY2026 revenue of $898 million, down 4.1% year over year but 0.6% above market expectations. Full-year revenue guidance is $3.55 billion at the midpoint, about 1% below analysts’ estimates. Non-GAAP EPS was $0.52, 50.1% above consensus. Shares rose 1.8% to $13.42 after the release.
4 min readDENTSPLY SIRONA (XRAY) said Medline Sinclair will expand distribution of its full technology portfolio across Canada starting Sept. 1, 2026, broadening a prior consumables-focused partnership. The company expects this could help scale digital dentistry solutions. Investors also look to its Aug. 6 Q2 2026 results and guidance on transformation spending and demand pressures.
5 min readDentsply Sirona (XRAY) will report Q2 results Thursday after market hours. The company previously reported $880M revenue, flat year over year, and EPS that beat full-year guidance estimates. For the upcoming quarter, analysts expect revenue to fall 4.6% y/y. The article cites an average analyst price target of $13.44 versus $14.25 current.
2 min readMorningstar’s weekly update for the week ended July 17 reported the Morningstar US Market Index down 1.53%, with energy up 4.54% and technology down 3.65%. S&P 500 fell 1.55% and Nasdaq 2.9%. PayPal (PYPL) rose 22.13% while Sandisk (SNDK) fell 29.31%. WTI crude rose to $82.54.
6 min readPDS Health and Dentsply Sirona said PDS Health practices have completed over 5 million CEREC chairside restorations. The companies cite 1,200+ CEREC systems installed across PDS Health practices and ongoing collaboration to support digital CAD/CAM workflows and same-day restorative care. Dentsply Sirona’s shares trade on Nasdaq as XRAY.
3 min readHOSEIN CLYDE purchased 6,500 shares of DENTSPLY SIRONA Inc. (XRAY) at $9.98 on 2026-06-15.
2 min readMCKEON BRIAN P purchased 10,000 indirectly-held shares of DENTSPLY SIRONA Inc. (XRAY) at $10.12 ($0.10M total) on 2026-06-12.
1 min readGladden Brian T purchased 9,985 shares of DENTSPLY SIRONA Inc. (XRAY) at $10.02 ($0.10M total) on 2026-06-15.
1 min readHOLDEN BETSY D purchased 10,086 shares of DENTSPLY SIRONA Inc. (XRAY) at $9.88 on 2026-06-11.
1 min read
